New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 25, 2014
08:55 EDTNVS, NVS, NVS, PG, PG, PGFDA to hold a public hearing
The FDA holds a public hearing on the Over-the-Counter Drug Monograph System at FDA Silver Spring, Maryland offices on March 25-26 at 9 am. Webcast Link
News For NVS;PG From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | all recent news | >>
July 29, 2015
15:01 EDTPGEarnings Watch: Procter & Gamble reporting amid CEO succession
Subscribe for More Information
08:24 EDTPGProcter & Gamble July weekly volatility elevated into Q4 and outlook
Procter & Gamble July weekly call option implied volatility is at 32, August is at 15, September is at 14; compared to its 52-week range of 10 to 19, suggesting large near term price movement into the expected release of Q4 results on July 30.
05:28 EDTNVSNovartis announces equity stake in Mereo BioPharma Group
Novartis announced a swap of clinical assets for equity with Mereo BioPharma Group. The deal involves compounds in areas of unmet medical need including BPS-804, to improve bone density in brittle bone syndrome, an orphan disease; BCT-197 for acute exacerbations in COPD, and BGS-649 for obese men with hypogonadotrophic hypogonadism to normalize testosterone levels. Under the terms of the agreement, Novartis will have an equity stake in Mereo and will share in the success of the development of these compounds, including a share on milestones and royalties on future commercial sales.
July 28, 2015
17:32 EDTPGProcter & Gamble appoints David Taylor CEO
Subscribe for More Information
08:13 EDTPGNew Procter & Gamble CEO unlikely to make major changes, says Bernstein
After The Wall Street Journal reported that Procter and Gamble had named David Taylor as its new CEO, Bernstein says the move was expected. The firm believes that the company needs changes in several areas, but it does not expect Taylor to make major changes. Bernstein keeps a $92 price target and Outperform rating on the shares.
07:11 EDTPGProcter & Gamble may issue 'safe' guidance, says Wells Fargo
Subscribe for More Information
July 27, 2015
18:16 EDTPGProcter & Gamble expected to name David Taylor as next CEO, WSJ says
Subscribe for More Information
17:57 EDTPGProcter & Gamble to name David Taylor as next CEO, Dow Jones says
Subscribe for More Information
July 24, 2015
10:56 EDTNVSNovartis announces FDA approval of Odomzo
Subscribe for More Information
09:02 EDTNVSLigand says Revolade recommended by CHMP for EU approval for SAA
Subscribe for More Information
07:17 EDTNVSNovartis combination therapy Tafinlar, Mekinist achieves regulatory milestones
Subscribe for More Information
July 22, 2015
07:03 EDTNVSIgnyta names Bernard Parker as Chief Commercial Officer
Subscribe for More Information
July 21, 2015
11:49 EDTNVSNovartis may sell Amgen's cancer drug as soon as September, Bloomberg says
Subscribe for More Information
10:01 EDTPGOn The Fly: Analyst Initiation Summary
Subscribe for More Information
05:20 EDTNVSNovartis backs FY15 revenue guidance of up mid-single digit
Subscribe for More Information
05:17 EDTNVSNovartis reports Q2 core EPS $1.27, consensus $1.24
Reports Q2 revenue $12.7B, consensus $12.44B. Further strengthening of USD impacted sales by -11% and core operating income by -13%. Growth Products, an indicator of the rejuvenation of the portfolio, contributed 35% of continuing operations net sales in Q2, and were up 24%. In Pharmaceuticals, Growth Products contributed 44% of division net sales in the quarter, and sales for these products were up 38%.
July 20, 2015
16:36 EDTPGProcter & Gamble initiated with a Neutral at Sterne Agee CRT
Subscribe for More Information
08:25 EDTNVSNovartis management to meet with JPMorgan
Subscribe for More Information
07:32 EDTNVSAlzheimer's Association to hold a conference
Subscribe for More Information
July 19, 2015
13:37 EDTPGProcter & Gamble shares look unattractive, Barron's says
Subscribe for More Information
1 | 2 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use